title: Universal fungal vaccines: could there be light at the end of the tunnel?
abstract: The complex nature of fungal pathogens, the intricate host-pathogen relationship and the health status of subjects in need of antifungal vaccination continue to hamper efforts to develop fungal vaccines for clinical use. That said, the rise of the universal vaccine concept is hoped to revive fungal vaccine research by expanding the pool of vaccine candidates worthy of clinical evaluation. It can do so through antigenic commonality-based screening for vaccine candidates from a wide range of pathogens and by reassessing the sizable collection of already available experimental and approved vaccines. Development of experimental vaccines protective against multiple fungal pathogens is evidence of the utility of this concept in fungal vaccine research. However, universal fungal vaccines are not without difficulties; for instance, development of vaccines with differential effectiveness is an issue that should be addressed. Additionally, rationalizing the development of universal fungal vaccines on health or economic basis could be contentious. Herein, universal fungal vaccines are discussed in terms of their potential usefulness and possible drawbacks.
authors.affiliation: Department of Medical Laboratory Sciences, College of Health Sciences, University of Sharjah, Sharjah, United Arab Emirates. mabdelhaq@sharjah.ac.ae
authors.forename: Mawieh
authors.initials: M
authors.lastname: Hamad
mesh_terms: D055808:Drug Discovery / Q000639:trends; D005657:Fungal Vaccines / Q000235:genetics / Q000276:immunology*; D006801:Humans; D009181:Mycoses / Q000517:prevention & control* / Q000628:therapy*; D014611:Vaccination / Q000379:methods*
chemical_list: D005657:Fungal Vaccines